Auris Medical Holding (EARS) Reports Q4 Loss of CHF0.16/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- Albanian police use teargas to disperse anti-graft demonstrators
Jefferies Cuts Price target on Auris Medical Holding (EARS) Following 4Q
March 15, 2016 8:30 AM EDTJefferies maintained a Buy rating on Auris Medical Holding AG (NASDAQ: EARS), and cut the price target to $8.00 (from $12.00), following the company's 4Q. Although management continues to see enrollment completion for TACTT2 this month, the topline results for both TACTT trials are... More
